Skip to main content

Agilent, Europroteome, Harvard Join GEML Consortium

 

NEW YORK, Dec 8 - Rosetta Inpharmatics said Friday Agilent Technologies, Europroteome, and the Harvard University Center for Genomic Research have joined its recently formed GEML consortium, a group that was formed to support the Gene Expression Markup Language format for gene expression and proteomics data as well as annotation.

Members of the group agree to exchange ideas regarding the future of gene expression data interchange and to participate in developing GEML, an open-standard XML file format that converts various gene expression data files into a common format. Members also commit to make their software products GEML-compatible.

“These organizations' membership in the GEML Community supports Rosetta Inpharmatics' goal of fostering collaboration and the sharing of gene expression and proteomics data for life science research," Mark Boguski, senior vice president of research and development at Rosetta, said in a statement.

Rosetta launched GEML in October and is distributing it for free along with a set of gene expression data visualization tools. Spotfire signed on as an initial member of the group.

For more information about the GEML file format and how to use it, go to www.geml.org .

 

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.